Nesidioblastosis del adulto coexistente con insulinoma

Laidlaw GF. Nesidioblastoma: the islet cell tumor of the pancreas. Am J Pathol. 1938;14:125-139.

Heitz PU, Klöppel G, Häcki WH, Polak JM, Pearse AG. Nesidioblastosis: the pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Morphologic and quantitative analysis of seven cases based on specific immunostaining and electron microscopy. Diabetes. 1977;26(7):632-42.

https://doi.org/10.2337/diab.26.7.632

Sempoux C, Guiot Y, Jaubert F, Rahier J. Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol. 2004;15(3):241-6.

https://doi.org/10.1385/EP:15:3:241

Sempoux C, Guiot Y, Dahan K, Moulin P, Stevens M, Lambot V, et al. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes. 2003;52:784-94.

https://doi.org/10.2337/diabetes.52.3.784

Fournet JC, Junien C. Genetics of congenital hyperinsulinism. Endocr Pathol. 2004;15(3):233-40.

https://doi.org/10.1385/EP:15:3:233

Reinecke-Lüthge A, Koschoreck F, Klöppel G. The molecular basis of persistent hyperinsulinemic hypoglycemia of infancy and its pathologic substrates. Virchows Arch. 2000;436(1):1-5.

https://doi.org/10.1007/PL00008192

Glaser B. Hyperinsulinism of the newborn. Semin Perinatol. 2000;24(2):150-63.

https://doi.org/10.1053/sp.2000.6365

Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, et al. Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome. Hum Genet. 2001;108(1):66-71.

https://doi.org/10.1007/s004390000432

Klöppel G, Anlauf M, Raffel A, Perren A, Knoefel WT. Adult diffuse nesidioblastosis: genetically or environmentally induced?. Human Pathology. 2008;39(1):3-8.

https://doi.org/10.1016/j.humpath.2007.09.010

Raffel A, Krausch M, Anlauf M, Wieben D, Braunstein S, Klöppel G, et al. Diffuse nesidioblastosis as a cause of hyperinsulinemic hypoglycemia in adults: a diagnostic and therapeutic challenge. Surgery. 2007;141(2):179-84.

https://doi.org/10.1016/j.surg.2006.04.015

Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am. 1989;18(1):45-74.

https://doi.org/10.1016/S0889-8529(18)30388-8

Van der Wal BC, de Krijger RR, de Herder WW, Kwekkeboom DJ, van der Ham F, Bonjer HJ, et al. Adult hyperinsulinemic hypoglycemia not caused by an insulinoma: a report of two cases. Virchows Arch. 2000;436(5):481-6.

https://doi.org/10.1007/s004280050476

Sandler R, Horwitz DL, Rubenstein AH, Kuzuya H. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus. Application of the C-peptide assay to diagnosis and therapy. Am J Med. 1975;59(5):730-6.

https://doi.org/10.1016/0002-9343(75)90234-X

Harness JK, Geelhoed GW, Thompson NW, Nishiyama RH, Fajans SS, Kraft RO, et al. Nesidioblastosis in adults. A surgical dilemma. Arch Surg 1981;116(5):575-80.

https://doi.org/10.1001/archsurg.1981.01380170055010

Anlauf M, Wieben D, Perren A, Sipos B, Komminoth P, Raffel A, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence and characterization of β-cell changes. Am J Surg Pathol. 2005;29(4):524-33.

https://doi.org/10.1097/01.pas.0000151617.14598.ae

Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, et al. Severe hypoglycemia post gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005;48(11):2236-40.

https://doi.org/10.1007/s00125-005-1933-x

Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249-54.

https://doi.org/10.1056/NEJMoa043690

Sperling MA, Menon RK. Hyperinsulinemic hypoglycaemia of infancy. Recent insights into ATP sensitive potassium channels, sulfonylurea receptors, molecular mechanisms, and treatment. Endocrinol Metab Clin North Am. 1999;28(4):695-708.

https://doi.org/10.1016/S0889-8529(05)70097-9

Dunne MJ, Kane C, Shepherd RM, Sanchez JA, James RF, Johnson PR, et al. Familial persistent huperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor. N Engl J Med. 1997;336(10):703-6.

https://doi.org/10.1056/NEJM199703063361005

Shyng SL, Ferrigni T, Shepard JB, Nestorowicz A, Glaser B, Permutt MA, et al. Functional analyses of novel mutations in the sulfonylurea receptor 1 associated with persistent hyperinsulinemic hypoglycemia of infancy. Diabetes. 1998;47(7):1145-51.

https://doi.org/10.2337/diabetes.47.7.1145

Nestorowicz A, Inagaki N, Gonoi T, Schoor KP, Wilson BA, Glaser B, et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes. 1997;46(11):1743-8.

https://doi.org/10.2337/diab.46.11.1743

Kukuvitis A, Deal C, Arbour L, Polychronakos C. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycaemia of infancy not linked to the sulfonylurea receptor locus. J Clin Endocrinol Metab. 1997;82(4):1192-4.

https://doi.org/10.1210/jc.82.4.1192

Thornton PS, Satin-Smith MS, Herold K, Glaser B, Chiu KC, Nestorowicz A, et al. Familial hyperinsulinism with apparent autosomal dominant inheritance: clinical and genetic differences from the autosomal recessive variant. J Pediatr. 1998;132(1):9-14.

https://doi.org/10.1016/S0022-3476(98)70477-9

Bell DS, Grizzle WE, Dunlap NE. Nesidioblastosis causing reversal of insulin-dependent diabetes and development ofhyperinsulinemic hypoglycaemia. Diabetes Care. 1995;18(10):1379-80.

https://doi.org/10.2337/diacare.18.10.1379

Rayman G, Santo M, Salomon F, Almog S, Paradinas FJ, Pinkhas J, et al. Hyperinsulinaemic hypoglycaemia due to chlorpropamida induced nesidioblastosis. J Clin Pathol. 1984;37(6):651-4.

https://doi.org/10.1136/jcp.37.6.651

Campbell IL, Harrison LC, Ley CJ, Colman PG, Ellis DW. Nesidioblastosis and multifocal pancreatic islet cell hyperplasia in an adult. Clinicopathologic features and in vitro pancreatic studies. Am J Clin Pathol. 1985;84(4):534-41.

https://doi.org/10.1093/ajcp/84.4.534

Kaczirek K, Soleiman A, Schindl M, Passler C, Scheuba C, Prager G, et al. Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism. Eur J Clin Investigation. 2003;33(6):488-92.

https://doi.org/10.1046/j.1365-2362.2003.01158.x

Farley DR, Van Heerden JA, Myers JL. Adult pancreatic nesidioblastosis: Unusual presentations of a rare entity. Arch Surg. 1994;129(3):329-32.

https://doi.org/10.1001/archsurg.1994.01420270107022

Thompson NW, Lloyd RV, Nishiyama RH, Vinik AI, Strodel WE, Allo MD , et al. MEN 1 pancreas: a histological and immunohistochemical study. World J Surg. 1984;8(4):561-74.

https://doi.org/10.1007/BF01654938

De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA. Role of endogenous glucagons like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes. 2003;52(2):365-71.

https://doi.org/10.2337/diabetes.52.2.365

List JF, Habener JF. Glucagon-like peptide 1 agonists and the development and growth of pancreatic b-cells. Am J Physiol Endocrinol Metab. 2004;286:E875-E881.

https://doi.org/10.1152/ajpendo.00007.2004

Brubaker PL, Drucker DJ. Minireview: glucagon-like polypeptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology. 2004;145:2653-9.

https://doi.org/10.1210/en.2004-0015

D'Alessio D, Vahl TP. Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes. Am J Physiol Endocrinol Metab. 2004; 286(6):E882-90.

https://doi.org/10.1152/ajpendo.00014.2004

Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003;144(12):5149-58.

https://doi.org/10.1210/en.2003-0323

Cryer PE. Glucose counterregulation: prevention and correction of hypoglycaemia in humans. Am J Physiol. 1993;264(2 Pt 1):E149-55.

https://doi.org/10.1152/ajpendo.1993.264.2.E149

Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, et al. Hierarchy of glycemic theresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol. 1991;260(1 PT1):E67-74.

https://doi.org/10.1152/ajpendo.1991.260.1.E67

Bani Sacchi T, Bani D, Biliotti G. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations. Int J Pancreatol. 1989;5(1):11-28.

Goudswaard WB, Houthoff HJ, Koudstaal J, Zwierstra RP. Nesidioblastosis and endocrine hyperplasia of the pancreas: a secondary phenomenon. Hum Pathol. 1986;17(1):46-54.

https://doi.org/10.1016/S0046-8177(86)80154-X

W Zumkeller. Nesidioblastosis. Endocr Relat Cancer. 1999;6(3):421-8.

https://doi.org/10.1677/erc.0.0060421

Zhao X, Stabile BE, Mo J, Wang J, French SW. Nesidioblastosis coexisting with islet cell tumor and intraductal papillary mucinous hyperplasia. Arch Pathol Lab Med. 2001;125(10):1344-7.

Leong AS, Slavotinek AH, Higgins BA. Nesidioblastosis, islet cell hyperplasia, and adenomatosis in a case of metastasizing insulinoma: contribution to the genesis of the islet of Langerhans. Diabetes Care. 1980;3(4):537-42.

https://doi.org/10.2337/diacare.3.4.537

Pour PM, Kazakoff K. Stimulation of islet cell proliferation enhances pancreatic ductal carcinogenesis in the hamster model. Am J Pathol. 1996;149(3):1017-25.

Götz W, Schucht C, Roth J, Theuring F, Herken R. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice. Am J Pathol. 1993;142(5):1493-503.

Jaffe R, Hashida Y, Yunis EJ. Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest. 1980;42(3):356-65.

Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab. 2000;85(11):3973-4.

https://doi.org/10.1210/jcem.85.11.6934

Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, et al. Forty-eight-hour fast: The diagnostic test for insulinoma. J Clin Endocrinol Metab. 2000;85(9):3222-6.

https://doi.org/10.1210/jcem.85.9.6807

Service FJ. Hypoglycemic disorders. N Engl J Med .1995; 332(17):1144-52.

https://doi.org/10.1056/NEJM199504273321707

Service FJ, Dale AJ, Elveback LR, Jiang NS. Insulinoma: clinical and diagnostic features of 60 consecutive cases. Mayo Clin Proc. 1976; 51(7):417-29.

Fajans SS, Vinik AI. Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am. 1989;18(1):45-74.

https://doi.org/10.1016/S0889-8529(18)30388-8

Harrison TS, Fajans SS, Floyd JC, Thompson NW, Rasbach DA, Santen RJ, et al. Prevalence of diffuse pancreatic beta islet cell disease with hyperinsulinism: problems in recognition and management. World J Surg. 1984;8(4):583-9.

https://doi.org/10.1007/BF01654942

Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992; 326(26):1721-6.

https://doi.org/10.1056/NEJM199206253262601

Botella Carretero JI, Valero Gonzalez MA, Lahera Vargas M, Aréchaga S, de Juan A, Varela Da Costa C, et al. Diagnostic localization of insulinoma and prognostic value of postoperative glycemia monitoring. Med Clin (Barc). 2002;118(6):201-4.

https://doi.org/10.1016/S0025-7753(02)72336-1

Borsato N, Chierichetti F, Zanco P, Rubello D, Pasquali C, Pedrazzoli S, et al. The role of 111 In-octreotide scintigraphy in the detection of APUD tumours: our experience in eighteen patients. Q J Nucl Med. 1995;39(4 supl 1):113-5.

O'Shea D, Rohrer-Theurs AW, Lynn JA, Jackson J.E, Bloom SR. Localization of insulinomas by selective intraarterial calcium injection. J Clin Endocrinol Metab. 1996;81(4):1623-7.

https://doi.org/10.1210/jcem.81.4.8636378

Brandle M, Pfammatter T, Spinas GA, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf). 2001;55(3):357-62.

https://doi.org/10.1046/j.1365-2265.2001.01335.x

Sung YM, Do YS, Lee MK, Shin SW, Liu WC, Choo SW, et al. Selective intra-arterial calcium stimulation with hepatic venous sampling for preoperative localization of insulinomas. Korean J Radiol. 2003;4(2):101-8.

https://doi.org/10.3348/kjr.2003.4.2.101

Witteles RM, Straus II FH, Sugg SL, Koka MR, Costa EA, Kaplan EL. Adult-onset nesidioblastosis causing hypoglycemia. Arch Surg. 2001;136(6):656-63.

https://doi.org/10.1001/archsurg.136.6.656

Jabri AL, Bayard C. Nesidioblastosis associated with hyperinsulinemic hypoglycemia in adults: review of the literature. Eur J Intern Med. 2004;15(7)407-10.

https://doi.org/10.1016/j.ejim.2004.06.012

Kane C, Lindley KJ, Johnson PR, James RF, Milla PJ, Aynsley-Green A, et al. Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin. J Clinl Invest. 1997;100(7):1888-93.

https://doi.org/10.1172/JCI119718

Fong TL, Warner NE, Kumar D. Pancreatic nesidioblastosis in adults. Diabetes Care. 1989;12(2):108-14.

https://doi.org/10.2337/diacare.12.2.108

W Zumkeller. Nesidioblastosis. Endocr Relat Cancer. 1999;6(3):421-8.

https://doi.org/10.1677/erc.0.0060421

Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N Engl J Med. 1998; 338(4):226-30.

https://doi.org/10.1056/NEJM199801223380404

Otonkoski T, Andersson S, Simell O. Somatostatin regulation of beta-cell function in the normal human fetuses and in neonates with persistent hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab. 1993;76(1):184-8.

https://doi.org/10.1210/jc.76.1.184

Lindley KJ, Dunne MJ, Kane C, Shepherd RM, Squires PE, James RF, et al. Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade. Arch Dis Child. 1996;74(5):373-8.

https://doi.org/10.1136/adc.74.5.373